Finance

Lists
SGRY:NASDAQ
Surgery Partners Inc
US$ १३.८९
+१.८३%
(+०.२५) 1D
US$ १३.८९
०.००% (०.००)
After hours
Closed: अक्टोबर ९, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGRY...
Open
US$ १३.६९
High
US$ १४.०६
Low
US$ १३.६०
Mkt. cap
१.८२ अरब
Avg. vol.
२२.५१ लाख
Volume
९.२९ लाख
52-wk high
US$ २३.४४
52-wk low
US$ ११.४१
EPS
-US$ ०.६९
Beta
१.९१
Shares outstanding
१३.०९ करोड
No. of employees
१६ हजार
Open
US$ १३.६९
High
US$ १४.०६
Low
US$ १३.६०
Mkt. cap
१.८२ अरब
Avg. vol.
२२.५१ लाख
Volume
९.२९ लाख
52-wk high
US$ २३.४४
52-wk low
US$ ११.४१
EPS
-US$ ०.६९
Beta
१.९१
Shares outstanding
१३.०९ करोड
No. of employees
१६ हजार
News stories
From web sources and news partners
About Surgery Partners Inc
CEO-
Employees१६ हजार
Founded२००४
Headquarters-
Sector-
Analyst ratings
Based on 9 analysts giving stock ratings to SGRY in the past 3 months
Buy
Buy
6
Hold
3
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SGRY in the last 3 months.
Highest
Current US$ १३.८९
US$ २४.०० (+७२.७९%)
Average
US$ १८.५० (+३३.१९%)
Lowest
US$ १४.०० (+०.७९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Hold
Maintained
US$ १४.००
+०.८%
10/07/2026
Ben Hendrix
RBC Capital
Buy
Maintained
US$ १९.००
+३६.८%
09/29/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
US$ २०.००
+४४%
09/18/2026
Ryan Langston
TD Cowen
Buy
Reiterated
US$ १९.००
+३६.८%
09/18/2026
Benjamin Rossi
J.P. Morgan
Hold
Reiterated
US$ १५.००
+८%
09/14/2026
Bill Sutherland
StoneX
Buy
Reiterated
US$ २४.००
+७२.८%
08/11/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
US$ १८.००
+२९.६%
08/10/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
08/11/2026
Gary Taylor
TD Cowen
Buy
Reiterated
US$ १९.००
+३६.८%
08/11/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
US$ १९.००
+३६.८%
07/13/2026
Brian Tanquilut
Jefferies
Buy
Maintained
US$ १७.००
+२२.४%
05/06/2026
A.J. Rice
UBS
Buy
Maintained
US$ २१.००
+५१.२%
03/10/2026
Last report
२०२६ अगस्ट १०
Fiscal period
Q2 2026
US$ ०.१० / US$ ०.०६
+५९.५७%beat
Revenue / Est. (USD)
८४.८९ करोड / ८३.०३ करोड
+२.२४%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
८२.१५ करोड
८८.५० करोड
८१.०९ करोड
८४.८९ करोड
Cost of goods sold
६२.६२ करोड
६७.२८ करोड
६५.०७ करोड
६५.८७ करोड
Cost of revenue
६२.६२ करोड
६७.२८ करोड
६५.०७ करोड
६५.८७ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.२४ करोड
२.३७ करोड
३.९३ करोड
३.६३ करोड
Operating expense
६.०२ करोड
७.८७ करोड
७.६१ करोड
७.३७ करोड
Total operating expenses
६८.६४ करोड
७५.१५ करोड
७२.६८ करोड
७३.२४ करोड
Operating income
१३.५१ करोड
१३.३५ करोड
८.४१ करोड
११.६५ करोड
Other non operating income
१६.०० लाख
८१.०० लाख
-
१४.०० लाख
EBT including unusual items
३.०८ करोड
४.२६ करोड
-३३.०० लाख
३.२३ करोड
EBT excluding unusual items
६.५४ करोड
७.२५ करोड
१.९१ करोड
५.३१ करोड
Income tax expense
५५.०० लाख
१.३६ करोड
-१२.०० लाख
२६.०० लाख
Effective tax rate
१७.८६%
३१.९२%
३६.३६%
८.०५%
Other operating expenses
-१७.०० लाख
-४९.०० लाख
-१७.०० लाख
-१९.०० लाख
Net income
-२.२७ करोड
-१.५० करोड
-३.५९ करोड
-१.५० करोड
Net profit margin
-२.७६%
-१.६९%
-४.४३%
-१.७७%
Earnings per share
०.१३
०.१२
-०.०३
०.१०
Interest and investment income
-
-
-
-
Interest expense
-७.६५ करोड
-७.५७ करोड
-६.९१ करोड
-७.१२ करोड
Net interest expenses
-७.६५ करोड
-७.५७ करोड
-६.९१ करोड
-७.१२ करोड
Depreciation and amortization charges
३.९५ करोड
५.९९ करोड
३.८५ करोड
३.९३ करोड
EBITDA
१७.४६ करोड
१९.३४ करोड
१२.२६ करोड
१५.५८ करोड
Gain or loss from assets sale
१.५६ करोड
१.१४ करोड
४३.०० लाख
२४.०० लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू